Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

N/ATerminatedNCT02040025

David Grant U.S. Air Force Medical Center2 enrolled

Overview

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetes Mellitus

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age equal to or greater than 18 2. Diagnosis of Type 1 or Type 2 diabetes mellitus 3. Prescribed EECP therapy in the DGMC EECP clinic 4. Medically cleared for EECP therapy 5. TRICARE beneficiary Exclusion Criteria: 1\. DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus

Locations (1)

David Grant USAF Medical Center

Travis Air Force Base, California, United States

Outcomes

Primary Outcomes

Change from baseline in TCOM (Transcutaneous oximetry measurement) values

Time frame: At baseline & post intervention, expected to be on average 30 minutes

Secondary Outcomes

Change from baseline in hemoglobin A1C laboratory values

Time frame: At baseline & post intervention, expected to be on average 30 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.